Patrick Cramer
Direttore/Membro del Consiglio presso WACKER CHEMIE AG
Profilo
Mr. Patrick Cramer is a President at Max Planck Gesellschaft zur Förderung der Wissenschaften eV.
He is on the Board of Directors at Wacker Chemie AG and Max-Delbrück-Centrum für Molekulare Medizin (MDC).
Mr. Cramer was previously employed as a Professor by Ludwig-Maximilians-Universität München.
He also served on the board at Max Planck Institute For Multidisciplinary Sciences, Max Planck Institute For Biophysical Chemistry and Gene Center Munich.
He received his doctorate degree from Ruprecht-Karls-Universität Heidelberg.
Posizioni attive di Patrick Cramer
| Società | Posizione | Inizio |
|---|---|---|
| WACKER CHEMIE AG | Direttore/Membro del Consiglio | 01/01/2023 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Direttore/Membro del Consiglio | - |
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
 Max Planck Gesellschaft zur Förderung der Wissenschaften eV Investment Trusts/Mutual FundsMiscellaneous Max Planck Gesellschaft zur Förderung der Wissenschaften eV (MPG) is a non-profit organization headquartered in Munich, Germany. The firm was founded in 1948 as a successor organization to the Kaiser Wilhelm Society. MPG conducts basic research in the natural sciences, life sciences, and humanities and provides investment advisory services to foundations. | Presidente | 22/06/2023 |
| University of Gottingen | Corporate Officer/Principal | 01/01/2017 |
Precedenti posizioni note di Patrick Cramer
| Società | Posizione | Fine |
|---|---|---|
| Max Planck Institute For Biophysical Chemistry | Direttore/Membro del Consiglio | 01/01/2021 |
| Ludwig-Maximilians-Universität München | Corporate Officer/Principal | 01/01/2013 |
| Gene Center Munich | Direttore/Membro del Consiglio | 01/01/2013 |
Formazione di Patrick Cramer
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| WACKER CHEMIE AG | Process Industries |
| Aziende private | 3 |
|---|---|
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Commercial Services |
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
Max Planck Gesellschaft zur Förderung der Wissenschaften eV Investment Trusts/Mutual FundsMiscellaneous Max Planck Gesellschaft zur Förderung der Wissenschaften eV (MPG) is a non-profit organization headquartered in Munich, Germany. The firm was founded in 1948 as a successor organization to the Kaiser Wilhelm Society. MPG conducts basic research in the natural sciences, life sciences, and humanities and provides investment advisory services to foundations. | Miscellaneous |
| Gene Center Munich |
- Borsa valori
- Insiders
- Patrick Cramer
